Ticker Details
Sagimet Biosciences Inc. Series A
IPO Date:	July 14, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$437.82M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.28 | 4.67%
Avg Daily Range (30 D):	$0.27 | 3.82%
Avg Daily Range (90 D):	$0.22 | 3.58%

Institutional Daily Volume
Avg Daily Volume:	.83M
Avg Daily Volume (30 D):	2.39M
Avg Daily Volume (90 D):	1.14M

Trade Size
Avg Trade Size (Sh.):	123
Avg Trade Size (Sh.) (30 D):	105
Avg Trade Size (Sh.) (90 D):	98

Institutional Trades
Total Institutional Trades:	80
Avg Institutional Trade:	$1.36M
Avg Institutional Trade (30 D):	$1.68M
Avg Institutional Trade (90 D):	$1.68M
Avg Institutional Trade Volume:	.22M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.38M
Avg Closing Trade (30 D):	$2.13M
Avg Closing Trade (90 D):	$2.13M
Avg Closing Volume:	382.62K

News

Apr 20, 2026 @ 11:00 AM Sagimet Biosciences Announces Appointment of Andre... Source: Na

Apr 6, 2026 @ 11:00 AM Sagimet Biosciences Announces Poster and Oral Pres... Source: Na

Feb 5, 2026 @ 12:00 PM Sagimet Biosciences Announces Participation in Two... Source: Na

Oct 24, 2025 @ 11:00 AM Denifanstat Achieved All Endpoints in the Treatmen... Source: Sagimet Biosciences

Sep 17, 2025 @ 11:00 AM Positive Phase 3 Results for Denifanstat for the T... Source: Sagimet Biosciences Inc.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.33	$-.3	$-1.58
Diluted EPS	$-.33	$-.3	$-1.58
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-10.65M	$-9.57M	$-51.04M
Operating Income / Loss	$-11.71M	$-10.77M	$-56.89M
Cost of Revenue
Net Cash Flow	$M	$2.53M	$-40.82M
PE Ratio